九安醫療(002432.SZ)子公司九安香港與月之暗面相關主體簽署投資相關協議
格隆匯3月24日丨九安醫療(002432.SZ)公吿,天津九安醫療電子股份有限公司(以下簡稱“公司”或“本公司”)連續3個交易日內(2024年3月20日、2024年3月21日、2024年3月22日)收盤價格升幅偏離值累計超過20%,根據《深圳證券交易所交易規則》的相關規定,屬於股票交易異常波動的情況。
為避免投資者受到市場傳言的影響,經公司自查,對相關事項披露如下:2023年8月,公司全資子公司九安香港有限公司(以下簡稱“九安香港”)與月之暗面相關主體簽署投資相關協議,投資金額等值於約1,000萬美元。2024年3月,公司參與投資的天津九尚一號管理諮詢合夥企業(有限合夥)(九安香港間接持有該合夥企業出資份額比例98.68%)與月之暗面相關主體簽署投資相關協議,投資金額等值於約2,000萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.